Radiation Oncology

Radiation therapy uses high-energy radiation to damage cancer cells' DNA and destroy their ability to divide and grow. It is delivered using linear accelerators, proton accelerators, metered cobalt-60 exposure, or brachytherapy where radioactive seeds are placed inside the patient on a temporary or permanent basis to kill cancer or relieve pain. The main radiation oncology society and annual conference is the American Society of Radiation Oncology (ASTRO).

RSS icon

PSMA PET mapping improves radiation therapy contouring after PCA recurrence

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

Thumbnail

First ever full course of the latest MR-guided radiation therapy treatments completed at Henry Ford Health

The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.

Thumbnail

MRI-guided radiotherapy for prostate cancer cuts treatment side effects in half

The team originally planned to enroll 300 men in the study, but the decisive results seen among the first 100 patients prompted them to cut enrollment in half.

liver cancer

Deep learning decreases CT radiation dose by 65% in patients with liver metastases

Scans using a smaller dose were accurate when detecting lesions 0.5 cm or larger but more research into low-contrast lesions is still necessary, experts cautioned.

Thumbnail

PSMA PET/CT better detects prostate cancer spread, long-term outcomes over conventional imaging

While the results offer indirect evidence, UCLA researchers said they support the clinical use of this technique for initial patient assessment.

insurance payer payment insurer

The $40 million price tag of prior authorizations exposed in new study

Data presented this week at the annual meeting of the American Society for Radiation Oncology shines a light on the massive financial burden of prior authorizations.

Thumbnail

MR imaging-guided SABR extends the lives of patients with inoperable pancreatic cancer

Miami Cancer Institute experts found the technique "significantly" prolonged overall survival, sharing their findings at the European Society for Radiotherapy and Oncology 2021 conference.

Thumbnail

Transformative prostate cancer therapy ‘should not be accepted’ without PET imaging

Two Stanford University experts made their case for using molecular imaging to select patients for 177-Lu-PSMA-617 in a new Journal of Nuclear Medicine editorial.

Displaying 41 - 48 of 67

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.